Skip to main content
SpringerLink
Log in

Muscle dysfunction in hypertrophic cardiomyopathy: What is needed to move to translation?

  • Review
  • Published:
Journal of Muscle Research and Cell Motility Aims and scope Submit manuscript

Abstract

Hypertrophic cardiomyopathy (HCM) is caused by mutations in sarcomere genes. As such, HCM provides remarkable opportunities to study how changes to the heart’s molecular motor apparatus may influence cardiac structure and function. Although the genetic basis of HCM is well-described, there is much more limited understanding of the precise consequences of sarcomere mutations—how they remodel the heart, and how these changes lead to the dramatic clinical consequences associated with HCM. More precise characterization of the mechanisms leading from sarcomere mutation to altered cardiac muscle function is critical to gain insight into fundamental disease biology and phenotypic evolution. Such knowledge will help foster development of novel treatment strategies aimed at correcting and preventing disease development in HCM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Abozguia K, Elliott P, McKenna W, Phan TT, Nallur-Shivu G, Ahmed I, Maher AR, Kaur K, Taylor J, Henning A, Ashrafian H, Watkins H, Frenneaux M (2010) Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy. Circulation 122:1562–1569

    Article  CAS  PubMed  Google Scholar 

  • Ashrafian H, Watkins H (2007) Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype. J Am Coll Cardiol 49:1251–1264

    Article  CAS  PubMed  Google Scholar 

  • Ashrafian H, Redwood C, Blair E, Watkins H (2003) Hypertrophic cardiomyopathy: a paradigm for myocardial energy depletion. Trends Genet 19:263–268

    Article  CAS  PubMed  Google Scholar 

  • Ashrafian H, Frenneaux MP, Opie LH (2007) Metabolic mechanisms in heart failure. Circulation 116:434–448

    Article  CAS  PubMed  Google Scholar 

  • Baudenbacher F, Schober T, Pinto JR, Sidorov VY, Hilliard F, Solaro RJ, Potter JD, Knollmann BC (2008) Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice. J Clin Invest 118:3893–3903

    CAS  PubMed Central  PubMed  Google Scholar 

  • Belus A, Piroddi N, Scellini B, Tesi C, D’Amati G, Girolami F, Yacoub M, Cecchi F, Olivotto I, Poggesi C (2008) The FHC-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils. J Physiol 586:3639–3644

    CAS  PubMed Central  PubMed  Google Scholar 

  • Bond LM, Tumbarello DA, Kendrick-Jones J, Buss F (2013) Small-molecule inhibitors of myosin proteins. Future Med Chem 5:41–52

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Borbély A, van der Velden J, Bronzwaer JGF, Papp Z, Édes I, Stienen GJM, Paulus WJ (2005) Cardiomyocyte stiffness in diastolic heart failure. Circulation 111:774–781

    Article  PubMed  Google Scholar 

  • Bottinelli R, Coviello DA, Redwood CS, Pellegrino MA, Maron BJ, Spirito P, Watkins H, Reggiani C (1998) A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Circ Res 82:106–115

    Article  CAS  PubMed  Google Scholar 

  • Chandra M, Tschirgi ML, Tardiff JC (2005) Increase in tension-dependent ATP consumption induced by cardiac troponin T mutation. Am J Physiol Heart Circ Physiol 289:H2112–H2119

    Article  CAS  PubMed  Google Scholar 

  • Coppini R, Ferrantini C, Yao L, Fan P, Del Lungo M, Stillitano F, Sartiani L, Tosi B, Suffredini S, Tesi C, Yacoub M, Olivotto I, Belardinelli L, Poggesi C, Cerbai E, Mugelli A (2013) Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy. Circulation 127:575–584

    Article  CAS  PubMed  Google Scholar 

  • Crilley JG, Boehm EA, Blair E, Rajagopalan B, Blamire AM, Styles P, McKenna WJ, Ostman-Smith I, Clarke K, Watkins H (2003) Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J Am Coll Cardiol 41:1776–1782

    Article  CAS  PubMed  Google Scholar 

  • Cuda G, Fananapazir L, Zhu WS, Sellers JR, Epstein ND (1993) Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy. J Clin Invest 91:2861–2865

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Elliott K, Watkins H, Redwood CS (2000) Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy. J Biol Chem 275:22069–22077

    Article  CAS  PubMed  Google Scholar 

  • Ferrantini C, Belus A, Piroddi N, Scellini B, Tesi C, Poggesi C (2009) Mechanical and energetic consequences of HCM-causing mutations. J Cardiovasc Transl Res 2:441–451

    Article  PubMed  Google Scholar 

  • Ferrantini C, Crocini C, Coppini R, Vanzi F, Tesi C, Cerbai E, Poggesi C, Pavone FS, Sacconi L (2013) The transverse-axial tubular system of cardiomyocytes. Cell Mol Life Sci 70:4695–4710

    Article  CAS  PubMed  Google Scholar 

  • Frey N, Brixius K, Schwinger RH, Benis T, Karpowski A, Lorenzen HP, Luedde M, Katus HA, Franz WM (2006) Alterations of tension-dependent ATP utilization in a transgenic rat model of hypertrophic cardiomyopathy. J Biol Chem 281:29575–29582

    Article  CAS  PubMed  Google Scholar 

  • Fujita H, Sugiura S, Momomura S, Omata M, Sugi H, Sutoh K (1997) Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. Molecular force level of mutant myosins may have a prognostic implication. J Clin Invest 99:1010–1015

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG (1990) A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 62:999–1006

    Article  CAS  PubMed  Google Scholar 

  • Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 124:2761–2796

    Google Scholar 

  • He H, Javadpour MM, Latif F, Tardiff JC, Ingwall JS (2007) R-92L and R-92W mutations in cardiac troponin T lead to distinct energetic phenotypes in intact mouse hearts. Biophys J 93:1834–1844

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • He H, Hoyer K, Tao H, Rice R, Jimenez J, Tardiff JC, Ingwall JS (2012) Myosin-driven rescue of contractile reserve and energetics in mouse hearts bearing familial hypertrophic cardiomyopathy-associated mutant troponin T is mutation-specific. J Physiol 590:5371–5388

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hernandez OM, Housmans PR, Potter JD (2001) Pathophysiology of cardiac muscle contraction and relaxation as a result of alterations in thin filament regulation. J Appl Physiol 90:1125–1136

    CAS  PubMed  Google Scholar 

  • Ho CY, Sweitzer NK, McDonough B, Maron BJ, Casey SA, Seidman JG, Seidman CE, Solomon SD (2002) Assessment of diastolic function with doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 105:2992–2997

    Article  PubMed  Google Scholar 

  • Ho CY, Carlsen C, Thune JJ, Havndrup O, Bundgaard H, Farrohi F, Rivero J, Cirino AL, Andersen PS, Christiansen M, Maron BJ, Orav EJ, Kober L (2009) Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy. Circ Cardiovasc Genet 2:314–321

    Article  PubMed Central  PubMed  Google Scholar 

  • Ho CY, López B, Coelho-Filho OR, Lakdawala NK, Cirino AL, Jarolim P, Kwong R, González A, Colan SD, Seidman JG, Díez J, Seidman CE (2010) Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 363:552–563

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ho CY, Abbasi SA, Neilan TG, Shah RV, Chen Y, Heydari B, Cirino AL, Lakdawala NK, Orav EJ, González A, López B, Díez J, Jerosch-Herold M, Kwong RY (2013) T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Circ Imaging 6:415–422

    Article  Google Scholar 

  • Homsher E, Lee DM, Morris C, Pavlov D, Tobacman LS (2000) Regulation of force and unloaded sliding speed in single thin filaments: effects of regulatory proteins and calcium. J Physiol 524:233–243

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Javadpour MM, Tardiff JC, Pinz I, Ingwall JS (2003) Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T. J Clin Invest 112:768–775

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Jung WI, Sieverding L, Breuer J, Hoess T, Widmaier S, Schmidt O, Bunse M, van Erckelens F, Apitz J, Lutz O, Dietze GJ (1998) 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 97:2536–2542

    Article  CAS  PubMed  Google Scholar 

  • Kim JB, Porreca GJ, Song L, Greenway SC, Gorham JM, Church GM, Seidman CE, Seidman JG (2007) Polony multiplex analysis of gene expression (pmage) in mouse hypertrophic cardiomyopathy. Science 316:1481–1484

    Article  CAS  PubMed  Google Scholar 

  • Kraft T, Witjas-Paalberends ER, Boontje NM, Tripathi S, Brandis A, Montag J, Hodgkinson JL, Francino A, Navarro-Lopez F, Brenner B, Stienen GJ, van der Velden J (2013) Familial hypertrophic cardiomyopathy: functional effects of myosin mutation R723G in cardiomyocytes. J Mol Cell Cardiol 57:13–22

    Article  CAS  PubMed  Google Scholar 

  • Lakdawala NK, Thune JJ, Maron BJ, Cirino AL, Havndrup O, Bundgaard H, Christiansen M, Carlsen CM, Dorval JF, Kwong RY, Colan SD, Kober LV, Ho CY (2011) Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy. Am J Cardiol 108:1606–1613

    Article  PubMed Central  PubMed  Google Scholar 

  • Lankford EB, Epstein ND, Fananapazir L, Sweeney HL (1995) Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest 95:1409–1414

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Li Y, Charles PY, Nan C, Pinto JR, Wang Y, Liang J, Wu G, Tian J, Feng HZ, Potter JD, Jin JP, Huang X (2010) Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy. J Mol Cell Cardiol 49:402–411

    Article  CAS  PubMed  Google Scholar 

  • Liu B, Lee RS, Biesiadecki BJ, Tikunova SB, Davis JP (2012) Engineered troponin C constructs correct disease-related cardiac myofilament calcium sensitivity. J Biol Chem 287:20027–20036

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lombardi R, Rodriguez G, Chen SN, Ripplinger CM, Li W, Chen J, Willerson JT, Betocchi S, Wickline SA, Efimov IR, Marian AJ (2009) Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms. Circulation 119:1398–1407

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lowey S (2002) Functional consequences of mutations in the myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy. Trends Cardiovasc Med 12:348–354

    Article  CAS  PubMed  Google Scholar 

  • Luedde M, Flögel U, Knorr M, Grundt C, Hippe HJ, Brors B, Frank D, Haselmann U, Antony C, Voelkers M, Schrader J, Most P, Lemmer B, Katus HA, Frey N (2009) Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy. J Mol Med 87:411–422

    Article  CAS  PubMed  Google Scholar 

  • Malik FI, Hartman JJ, Elias KA, Morgan BP, Rodriguez H, Brejc K, Anderson RL, Sueoka SH, Lee KH, Finer JT, Sakowicz R, Baliga R, Cox DR, Garard M, Godinez G, Kawas R, Kraynack E, Lenzi D, Lu PP, Muci A, Niu C, Qian X, Pierce DW, Pokrovskii M, Suehiro I, Sylvester S, Tochimoto T, Valdez C, Wang W, Katori T, Kass DA, Shen YT, Vatner SF, Morgans DJ (2011) Cardiac myosin activation: a potential therapeutic approach for systolic heart failure. Science 331:1439–1443

    Article  CAS  PubMed  Google Scholar 

  • Marian AJ, Roberts R (2001) The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 33:655–670

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the cardia study. Circulation 92:785–789

    Article  CAS  PubMed  Google Scholar 

  • Maron BJ, Seidman JG, Seidman CE (2004) Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol 44:2125–2132

    Article  PubMed  Google Scholar 

  • Marston SB (2011) How do mutations in contractile proteins cause the primary familial cardiomyopathies? J Cardiovasc Transl Res 4:245–255

    Article  PubMed  Google Scholar 

  • Marston SB, Copeland O, Jacques A, Livesey K, Tsang V, McKenna WJ, Jalilzadeh S, Carballo S, Redwood C, Watkins H (2009) Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency. Circ Res 105:219–222

    Article  CAS  PubMed  Google Scholar 

  • Miller G, Maycock J, White E, Peckham M, Calaghan S (2003) Heterologous expression of wild-type and mutant beta-cardiac myosin changes the contractile kinetics of cultured mouse myotubes. J Physiol 548:167–174

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Narolska NA, van Loon RB, Boontje NM, Zaremba R, Eiras Penas S, Russell J, Spiegelenberg SR, Huybregts MAJM, Visser FC, de Jong JW, van der Velden J, Stienen GJM (2005) Myocardial contraction is 5-fold more economical in ventricular than in atrial human tissue. Cardiovasc Res 65:221–229

    Article  CAS  PubMed  Google Scholar 

  • Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, Kristinsson A, Roberts R, Sole M, Maron BJ, Seidman JG, Seidman CE (1998) Mutations in the gene for cardiac myosin-binding protein c and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 338:1248–1257

    Article  CAS  PubMed  Google Scholar 

  • Oleszczuk M, Robertson IM, Li MX, Sykes BD (2010) Solution structure of the regulatory domain of human cardiac troponin C in complex with the switch region of cardiac troponin I and W7: the basis of W7 as an inhibitor of cardiac muscle contraction. J Mol Cell Cardiol 48:925–933

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Palmer BM, Wang Y, Teekakirikul P, Hinson JT, Fatkin D, Strouse S, Vanburen P, Seidman CE, Seidman JG, Maughan DW (2008) Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex. Am J Physiol Heart Circ Physiol 294:H1939–H1947

    Article  CAS  PubMed  Google Scholar 

  • Palmiter KA, Tyska MJ, Haeberle JR, Alpert NR, Fananapazir L, Warshaw DM (2000) R403Q and L908V mutant beta-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level. J Muscle Res Cell Motil 21:609–620

    Article  CAS  PubMed  Google Scholar 

  • Piroddi N, Belus A, Scellini B, Tesi C, Giunti G, Cerbai E, Mugelli A, Poggesi C (2007) Tension generation and relaxation in single myofibrils from human atrial and ventricular myocardium. Pflugers Arch 454:63–73

    Article  CAS  PubMed  Google Scholar 

  • Richard P, Villard E, Charron P, Isnard R (2006) The genetic bases of cardiomyopathies. J Am Coll Cardiol 48:A79–A89

    Article  CAS  Google Scholar 

  • Robertson IM, Li MX, Sykes BD (2009) Solution structure of human cardiac troponin C in complex with the green tea polyphenol, (−)−epigallocatechin 3-gallate. J Biol Chem 284:23012–23023

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Roopnarine O, Leinwand LA (1998) Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy. Biophys J 75:3023–3030

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sata M, Ikebe M (1996) Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome. J Clin Invest 98:2866–2873

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Schober T, Huke S, Venkataraman R, Gryshchenko O, Kryshtal D, Hwang HS, Baudenbacher FJ, Knollmann BC (2012) Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia. Circ Res 111:170–179

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Seebohm B, Matinmehr F, Köhler J, Francino A, Navarro-Lopéz F, Perrot A, Ozcelik C, McKenna WJ, Brenner B, Kraft T (2009) Cardiomyopathy mutations reveal variable region of myosin converter as major element of cross-bridge compliance. Biophys J 97:806–824

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Seidman JG, Seidman C (2001) The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104:557–567

    Article  CAS  PubMed  Google Scholar 

  • Semsarian C, Ahmad I, Giewat M, Georgakopoulos D, Schmitt JP, McConnell BK, Reiken S, Mende U, Marks AR, Kass DA, Seidman CE, Seidman JG (2002) The l-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model. J Clin Invest 109:1013–1020

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sequeira V, Wijnker PJ, Nijenkamp LL, Kuster DW, Najafi A, Witjas-Paalberends ER, Regan JA, Boontje N, Ten Cate FJ, Germans T, Carrier L, Sadayappan S, van Slegtenhorst MA, Zaremba R, Foster DB, Murphy AM, Poggesi C, Dos Remedios C, Stienen GJ, Ho CY, Michels M, van der Velden J (2013) Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations. Circ Res 112:1491–1505

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sommese RF, Sung J, Nag S, Sutton S, Deacon JC, Choe E, Leinwand LA, Ruppel K, Spudich JA (2013) Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human β-cardiac myosin motor function. Proc Natl Acad Sci USA 110:12607–12612

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Spindler M, Saupe KW, Christe ME, Sweeney HL, Seidman CE, Seidman JG, Ingwall JS (1998) Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. J Clin Invest 101:1775–1783

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Stelzer JE, Dunning SB, Moss RL (2006) Ablation of cardiac myosin-binding protein-C accelerates stretch activation in murine skinned myocardium. Circ Res 98:1212–1218

    Article  CAS  PubMed  Google Scholar 

  • Sweeney HL, Feng HS, Yang Z, Watkins H (1998) Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function. Proc Natl Acad Sci U S A 95:14406–14410

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Tyska MJ, Hayes E, Giewat M, Seidman CE, Seidman JG, Warshaw DM (2000) Single molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. Circ Res 86:737–744

    Article  CAS  PubMed  Google Scholar 

  • Van Dijk SJ, Dooijes D, dos Remedios C, Michels M, Lamers JM, Winegrad S, Schlossarek S, Carrier L, ten Cate FJ, Stienen GJ, van der Velden J (2009) Cardiac myosin-binding protein mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation 119:1473–1483

    Article  PubMed  Google Scholar 

  • Witjas-Paalberends ER, Piroddi N, Stam K, van Dijk SJ, Oliviera VS, Ferrara C, Scellini B, Hazebroek M, ten Cate FJ, van Slegtenhorst M, dos Remedios C, Niessen HW, Tesi C, Stienen GJ, Heymans S, Michels M, Poggesi C, van der Velden J (2013) Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy. Cardiovasc Res 99:432–441

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Financial support by Telethon-Italy (Grant No. GGP13162) and the 7th Framework Program of the European Union (‘BIG-HEART’, Grant Agreement 241577) to CP is gratefully acknowledged.

CYH is supported by grants from the National Institutes of Health (1P50HL112349-01, 1UO1 HG006500-01, 1U01HL117006).

Author information

Authors and Affiliations

  1. Department of Experimental and Clinical Medicine, University of Florence, Viale Morgagni 63, 50134, Florence, Italy

    Corrado Poggesi

  2. Cardiovascular Division, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA, 02115, USA

    Carolyn Y. Ho

Authors
  1. Corrado Poggesi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carolyn Y. Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Corrado Poggesi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Poggesi, C., Ho, C.Y. Muscle dysfunction in hypertrophic cardiomyopathy: What is needed to move to translation?. J Muscle Res Cell Motil 35, 37–45 (2014). https://doi.org/10.1007/s10974-014-9374-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10974-014-9374-0

Keywords

Search

Navigation